WCM
AMAG

Weld Capital Management’s AMAG Pharmaceuticals AMAG Stock Holding History

Weld Capital Management’s Portfolio AMAG Stock Details AMAG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-16,960
Closed -$169K – 1094
2019
Q2 		$169K Sell
16,960
-5,188
-23% -$56K 0.03% 665
2019
Q1 		$285K Buy
22,148
+2,453
+12% +$36.5K 0.05% 523
2018
Q4 		$299K Buy
+19,695
New +$375K 0.07% 496

Other funds holding AMAG

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Weld Capital Management's AMAG Position: Q3 2019 in Review

Weld Capital Management sold out of AMAG Pharmaceuticals (AMAG) in Q3 2019, closing a stake of 16,960 shares — an estimated $169K sold.

Weld Capital Management first reported a position in AMAG in Q4 2018 and held it in 3 quarters. The position peaked at $299K in Q4 2018. 156 funds tracked by Wall St. Rank hold AMAG as of Q3 2019.

  • Weld Capital Management reported no remaining AMAG Pharmaceuticals position as of Q3 2019 after selling out during the quarter.
  • Weld Capital Management sold 16,960 AMAG Pharmaceuticals shares in Q3 2019, an estimated $169K.
  • Weld Capital Management first reported a position in AMAG Pharmaceuticals in Q4 2018 and held it in 3 quarters.
  • Weld Capital Management's AMAG Pharmaceuticals position peaked at $299K in Q4 2018.
  • 156 funds tracked by Wall St. Rank held AMAG Pharmaceuticals as of Q3 2019.

Based on Weld Capital Management's 13F filing for Q3 2019, filed 14 Nov 2019.